Embedded Files
PRESS RELEASES
Antelope Surgical Solutions Achieves Commercial Investigational New Drug (IND) Approval for PSMA-Fluorescent Novel Drug AS1986NS, Nov 12, 2024.
Primo Biotechnology Partners with Antelope Surgical Solutions for First FDA-Approved Phase I/II Trial of AS1986NS, Dec 20, 2024.
Antelope Surgical Solutions and SHINE Announce Partnership to Advance Clinical Radiopharmaceutical Development, Jan 9, 2025.
Follow us on LinkedIn.
Page updated
Report abuse